• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黑色素瘤的分子病理学:黑素细胞肿瘤的综合分类。

The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia.

机构信息

Departments of Dermatology and Pathology, Cardiovascular Research Institute, University of California, San Francisco, California 94158-9001; email:

出版信息

Annu Rev Pathol. 2014;9:239-71. doi: 10.1146/annurev-pathol-012513-104658.

DOI:10.1146/annurev-pathol-012513-104658
PMID:24460190
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4831647/
Abstract

Melanomas comprise multiple biologically distinct categories, which differ in cell of origin, age of onset, clinical and histologic presentation, pattern of metastasis, ethnic distribution, causative role of UV radiation, predisposing germ-line alterations, mutational processes, and patterns of somatic mutations. Neoplasms are initiated by gain-of-function mutations in one of several primary oncogenes, which typically lead to benign melanocytic nevi with characteristic histologic features. The progression of nevi is restrained by multiple tumor-suppressive mechanisms. Secondary genetic alterations override these barriers and promote intermediate or overtly malignant tumors along distinct progression trajectories. The current knowledge about the pathogenesis and clinical, histologic, and genetic features of primary melanocytic neoplasms is reviewed and integrated into a taxonomic framework.

摘要

黑素瘤包含多个生物学上不同的类别,这些类别在细胞起源、发病年龄、临床和组织学表现、转移模式、种族分布、紫外线辐射的致病作用、潜在的种系改变、突变过程以及体细胞突变模式等方面存在差异。肿瘤是由几种主要致癌基因之一的功能获得性突变引发的,这些基因通常导致具有特征性组织学特征的良性黑素细胞痣。多个肿瘤抑制机制限制了痣的进展。继发性遗传改变会突破这些障碍,并沿着不同的进展轨迹促进中间或明显恶性肿瘤。本文回顾了原发性黑素细胞肿瘤的发病机制以及临床、组织学和遗传学特征,并将这些知识整合到一个分类框架中。

相似文献

1
The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia.黑色素瘤的分子病理学:黑素细胞肿瘤的综合分类。
Annu Rev Pathol. 2014;9:239-71. doi: 10.1146/annurev-pathol-012513-104658.
2
Melanocytic nevi and tumor progression: perspectives concerning histomorphology, melanoma risk and molecular genetics.黑素细胞痣与肿瘤进展:关于组织形态学、黑色素瘤风险及分子遗传学的观点
Dermatology. 1993;187(2):86-90. doi: 10.1159/000247212.
3
Acquired dysplastic melanocytic nevi and cutaneous melanoma: precursors and prevention.获得性发育异常性黑素细胞痣与皮肤黑色素瘤:前驱病变与预防
Ann Intern Med. 1985 Apr;102(4):546-8. doi: 10.7326/0003-4819-102-4-546.
4
Black and Brown Oro-facial Mucocutaneous Neoplasms.黑色和棕色口腔颌面部黏膜皮肤肿瘤
Head Neck Pathol. 2019 Mar;13(1):56-70. doi: 10.1007/s12105-019-01008-2. Epub 2019 Jan 29.
5
High frequency of PTEN mutations in nevi and melanomas from xeroderma pigmentosum patients.着色性干皮病患者痣和黑色素瘤中PTEN突变的高频率。
Pigment Cell Melanoma Res. 2014 May;27(3):454-64. doi: 10.1111/pcmr.12226. Epub 2014 Feb 21.
6
Classifying melanocytic tumors based on DNA copy number changes.基于DNA拷贝数变化对黑素细胞肿瘤进行分类。
Am J Pathol. 2003 Nov;163(5):1765-70. doi: 10.1016/S0002-9440(10)63536-5.
7
The Genetic Evolution of Melanoma from Precursor Lesions.黑色素瘤从前期病变的遗传进化。
N Engl J Med. 2015 Nov 12;373(20):1926-36. doi: 10.1056/NEJMoa1502583.
8
Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics.深部穿透性痣样交界性肿瘤:一类具有恶性潜能且细胞遗传学正常的特殊含混不清黑素细胞肿瘤亚型。
Eur J Dermatol. 2014 Sep-Oct;24(5):594-602. doi: 10.1684/ejd.2014.2393.
9
Transcriptome sequencing of melanocytic nevi and melanomas from Grm1 transgenic mice to determine melanoma driver mutations.对来自Grm1转基因小鼠的黑素细胞痣和黑色素瘤进行转录组测序,以确定黑色素瘤驱动突变。
Pigment Cell Melanoma Res. 2014 Jul;27(4):678-80. doi: 10.1111/pcmr.12244. Epub 2014 Apr 7.
10
Patterns of melastatin mRNA expression in melanocytic tumors.黑素细胞肿瘤中褪黑素受体1型(Melastatin)mRNA的表达模式
Hum Pathol. 2000 Nov;31(11):1346-56.

引用本文的文献

1
The examination of in vitro photosensitizing efficacy of aloe-emodin loaded liposome following photodynamic therapy on melanoma cell lines.光动力疗法后芦荟大黄素负载脂质体对黑色素瘤细胞系的体外光敏疗效研究
Sci Rep. 2025 Aug 6;15(1):28833. doi: 10.1038/s41598-025-14777-4.
2
Bayesian inference of fitness landscapes via tree-structured branching processes.通过树状分支过程对适应度景观进行贝叶斯推断。
Bioinformatics. 2025 Jul 1;41(Supplement_1):i160-i169. doi: 10.1093/bioinformatics/btaf193.
3
Tri-Phenyl-Phosphonium-Based Nano Vesicles: A New In Vitro Nanomolar-Active Weapon to Eradicate PLX-Resistant Melanoma Cells.

本文引用的文献

1
Clonal BRAF mutations in melanocytic nevi and initiating role of BRAF in melanocytic neoplasia.黑素细胞痣中的克隆 BRAF 突变及其在黑素细胞肿瘤发生中的起始作用。
J Natl Cancer Inst. 2013 Jun 19;105(12):917-9. doi: 10.1093/jnci/djt119. Epub 2013 May 20.
2
Suppression of nucleotide metabolism underlies the establishment and maintenance of oncogene-induced senescence.核苷酸代谢的抑制是癌基因诱导衰老的建立和维持的基础。
Cell Rep. 2013 Apr 25;3(4):1252-65. doi: 10.1016/j.celrep.2013.03.004. Epub 2013 Apr 4.
3
Long-term hazards of neonatal blue-light phototherapy.
基于三苯基膦的纳米囊泡:一种用于根除对PLX耐药的黑色素瘤细胞的新型体外纳摩尔活性武器。
Int J Mol Sci. 2025 Mar 30;26(7):3227. doi: 10.3390/ijms26073227.
4
A Retrospective Analysis of Ambiguous Spitz Tumors Using Next-Generation Sequencing.使用二代测序对不典型斯皮茨瘤进行回顾性分析。
Cancers (Basel). 2025 Apr 4;17(7):1227. doi: 10.3390/cancers17071227.
5
Cutaneous melanoma.皮肤黑色素瘤
Nat Rev Dis Primers. 2025 Apr 3;11(1):23. doi: 10.1038/s41572-025-00603-8.
6
Evaluation of a Norcantharidin Nanoemulsion Efficacy for Treating B16F1-Induced Melanoma in a Syngeneic Murine Model.去甲斑蝥素纳米乳剂治疗同基因小鼠模型中B16F1诱导的黑色素瘤的疗效评估。
Int J Mol Sci. 2025 Jan 30;26(3):1215. doi: 10.3390/ijms26031215.
7
Carboxylesterase 1-mediated endocannabinoid metabolism in skin: role in melanoma progression in BRaf/Pten mice.羧酸酯酶1介导的皮肤内源性大麻素代谢:在BRAF/PTEN小鼠黑色素瘤进展中的作用
Cancer Metab. 2025 Feb 11;13(1):8. doi: 10.1186/s40170-025-00378-2.
8
[WHO classification of melanocytic tumours].[世界卫生组织黑色素细胞肿瘤分类]
Dermatologie (Heidelb). 2025 Mar;76(3):121-126. doi: 10.1007/s00105-025-05468-2. Epub 2025 Jan 28.
9
Exploring STK3 in melanoma: a systematic review of signaling networks and therapeutic opportunities.探讨黑色素瘤中的 STK3:信号网络及治疗机会的系统综述。
Mol Biol Rep. 2024 Nov 22;52(1):8. doi: 10.1007/s11033-024-10064-z.
10
Transcriptomic analysis of melanoma cells reveals an association of α-synuclein with regulation of the inflammatory response.黑色素瘤细胞转录组分析揭示 α-突触核蛋白与炎症反应调节有关。
Sci Rep. 2024 Nov 7;14(1):27140. doi: 10.1038/s41598-024-78777-6.
新生儿蓝光光疗的长期危害。
Br J Dermatol. 2013 Aug;169(2):243-9. doi: 10.1111/bjd.12335.
4
Multiple congenital melanocytic nevi and neurocutaneous melanosis are caused by postzygotic mutations in codon 61 of NRAS.多发性先天性黑素细胞痣和神经皮肤黑色素沉着症是由 NRAS 密码子 61 的合子后突变引起的。
J Invest Dermatol. 2013 Sep;133(9):2229-36. doi: 10.1038/jid.2013.70. Epub 2013 Feb 7.
5
Highly recurrent TERT promoter mutations in human melanoma.人类黑色素瘤中高度复发的 TERT 启动子突变。
Science. 2013 Feb 22;339(6122):957-9. doi: 10.1126/science.1229259. Epub 2013 Jan 24.
6
TERT promoter mutations in familial and sporadic melanoma.TERT 启动子突变与家族性和散发性黑色素瘤。
Science. 2013 Feb 22;339(6122):959-61. doi: 10.1126/science.1230062. Epub 2013 Jan 24.
7
Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma.眼黑色素瘤中剪接因子 SF3B1 密码子 625 位的反复突变。
Nat Genet. 2013 Feb;45(2):133-5. doi: 10.1038/ng.2523. Epub 2013 Jan 13.
8
NRAS and BRAF mutations in cutaneous melanoma and the association with MC1R genotype: findings from Spanish and Austrian populations.NRAS 和 BRAF 突变在皮肤黑色素瘤中的作用及其与 MC1R 基因型的关系:来自西班牙和奥地利人群的研究结果。
J Invest Dermatol. 2013 Apr;133(4):1027-33. doi: 10.1038/jid.2012.385. Epub 2012 Oct 25.
9
Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma.5-羟甲基胞嘧啶的缺失是黑色素瘤的一个表观遗传标志。
Cell. 2012 Sep 14;150(6):1135-46. doi: 10.1016/j.cell.2012.07.033.
10
Loss of the tumor suppressor BAP1 causes myeloid transformation.抑癌基因 BAP1 的缺失可导致髓系转化。
Science. 2012 Sep 21;337(6101):1541-6. doi: 10.1126/science.1221711. Epub 2012 Aug 9.